| |
|
URISA hosted its second GIS in Public Health
event in Providence, RI in early June. The attendance, to everyone's
delight, matched that of the event two years ago in New Orleans. There
were visitors from many countries including the Far East and former
Soviet republics. A pair of simultaneous interpreters had to do some
heavy lifting to keep up with the specialized language of this event.
These are, in fact, benefits/positives, he argued. He listed these corresponding responses:
The Who, What and How of Mapping Christensen then went on to what I consider to be the most important part of the most important session of this, or perhaps any recent conference in memory: the order for attacking a mapping (or frankly any design) project. Essentially he suggested we jump over the third step: identifying the user (who), and go directly to the fourth (how). The correct process looks like this: First: What Second: Why Then, third: How NO STOP! Third: Who. Fourth: How So, how do you define the "who"? Christensen described how to define personas, as is done in advertising. For Rhiza's mapping clients that might mean putting people on a grid with axes from objective to biased in one direction and low science/high science on the other. After mapping some personas, the team needs to select which of the personas to support. It's unlikely "all" will be supportable with a single implementation. He noted that it never works to put out a fully functional app and then trim it back for beginners. He then went on to the "how," and offered the many possible options (and technologies) available. The trick is to select the one to serve the users identified in the "who" part of the development. Pandemic/Avian Flu Dr. Michael Shambaugh-Miller of the University of Nebraska used a federal grant to help support populations at risk for flu. Interestingly, the federal and state government did not know who these people were, so the team built its own list (those who spoke English as a second language, those in assisted living - about eight datasets, plus or minus). The state has 19 public health offices funded by the tobacco settlement. The grant covered installing ArcGIS in each office and training one specially selected individual. These users developed datasets to a standard, such that they could be, and eventually were, knit together in a statewide "Guardian" system. Thus any office could download and run queries against any part of the dataset. Each year there's a "test" flu to ensure the local offices can query to a specific population. Further, the individual offices have begun to use the system for participating in other grants and adding to various health data collections. The next step involves integrating this system with other state health systems. Total cost: $116,000 (and it's sustainable). Dr. Brown returned to provide a primer on the biology of H1N1. It was fascinating, but my biology basics were not sufficient to keep up! Jeff Chistensen returned to tell the story of Rhiza Labs' experience and lessons learned tracking H1N1. The company began working with Dr. Henry Niman in part because his use of Google My Maps for his tracking was about to hit a wall. Dr. Niman looked at news and other reports and manually dropped pins, added blurbs or copied text from sources to build his original My Map. The map, "the only game in town" collecting data from official and many unofficial sources, was widely popular because unlike official offerings from the Center for Disease Control and the WHO, Dr. Niman's map provided perhaps not entirely accurate but seemingly actionable data. The other offerings were more in the vein of "infographics." For example, visitors to CDC or WHO maps couldn't determine if known cases increased from yesterday to today or if a parent might want to keep a child home from school. The Rhiza Labs team quickly jumped on the challenge and asked: What do people want on a map? The answers based on what they saw and heard included:
So what did Rhiza do? It created a submission form for those who wanted to contribute (to get geocode-worthy addresses) that was quick and dirty, and required a URL source. Contributions were "controlled" by requiring registration. Curators - Dr. Niman and his team, a total of four people - then used that input among other sources. The data, made available via Creative Commons license, were used by the likes of Walgreens to manage its Tamiflu supply chain and businesses that wanted to track the outbreak in the context of their distributed employees, among others. It also popped up in an emergent reality game in Hawaii and an iPhone app. I was lucky enough to get to ask my question among the many, many from the attendees. I wanted to know what single aspect of the implementation Rhiza would have changed in retrospect. Christensen quickly pointed to a tool to ensure incidents were not mapped more than once. If you are at all interested in volunteered geographic information for health or other purposes, I suggest you keep an eye on Rhiza Labs. Observations The ideas from the first breakout session that I attended, which related to identifying and serving an audience with maps, continued to pop up throughout the day. At lunch, I joined a roundtable discussion about Google Earth and public health. One participant noted that her organization was launching a data portal with some mapping but they had heard suggestions they should look into Google Earth in the future. She'd never used Google Earth and was curious to learn about it. I could not help going back to the morning's discussion and thinking, "Google Earth is great, but who are you serving and what do you hope to achieve?" Only after answering those questions can you consider the "how." Another participant jumped in to suggest Google Earth Professional. But again, not having the why or the who, I was concerned that the suggestion, while well-meant, jumped the gun. I was disappointed that given Google's involvement and interest in health data and records, no one from the company or Google.org attended. Another theme reappeared in papers and discussions: the challenge of delivering data and tools to both novice and expert users. That seems to plague organizations worldwide. Also, the challenges of acquiring and using health data appeared. My sense was that those who had data, mapped them (one paper was a series of maps correlating health disparities with other factors), and those who didn't have data, struggled to get them any way possible (as was done in the Nebraska and Rhiza Labs presentations noted above). Perhaps most noteworthy during my single day at the three-day event was the confirmation that the challenges in health GIS mirror those across all uses of GIS. Further, those challenges are not that different from the ones faced 30 or 40 years ago in the early years of the digital mapping technology. More about this author... |
LI Articles
|
Your Comments All comments provided in this section are those of the individual who has created the post. These are not the opinions of Directions Media, its editors, staff or owners unless otherwise noted. Directions Media retains the right to edit or delete any comments posted herein.
|

